Related Experiment Videos

Sickle cell lung disease

Insights

Sickle cell disease patients with fever and lung infiltrates often have infection, but pulmonary infarction is a possibility. Differentiating between pneumonia and infarction requires considering patient age, symptoms, and lab findings.

Area of Science:

  • Hematology
  • Pulmonology
  • Infectious Diseases

Background:

  • Sickle cell disease (SCD) presents unique challenges in diagnosing pulmonary complications.
  • Fever and lung infiltrates in SCD patients are commonly attributed to infection, but other causes exist.

Purpose of the Study:

  • To differentiate between infectious pneumonia and pulmonary infarction in patients with sickle cell disease.
  • To identify clinical and laboratory features that distinguish these conditions.

Main Methods:

  • Review of clinical presentations, imaging findings, and laboratory results in SCD patients with fever and lung infiltrates.
  • Comparison of features between patients diagnosed with pneumonia versus pulmonary infarction.

Main Results:

  • Pulmonary infarction can mimic pneumonia in SCD, even with negative cultures.
  • Pneumonia is more common in younger patients (<5 years) with purulent sputum and upper lobe infiltrates.
  • Thromboembolic disease is suggested by coexisting crisis, low leukocyte alkaline phosphatase, and microangiopathic changes.

Conclusions:

  • Distinguishing pneumonia from pulmonary infarction in SCD requires careful evaluation of multiple factors.
  • Fat embolism syndrome, secondary to bone marrow necrosis, is a recognized complication in SCD.

Related Concept Videos